Drawing for CALSCORBATE

USPTO serial 71478702

CALSCORBATE

Reviewed by CopyMark Law Group

Reg. 0415379Status 900
Filing date
Status date
Registration date
Aug 7, 1945
Examiner
—
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CALSCORBATE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher Serbagi

CHRISTOPHER SERBAGI LAW OFFICES OF CHRISTOPHER SERBAGI488 MADISON AVE STE 1120NEW YORK, NY 10022UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
018INTRAVENOUS OR INTRAMUSCULAR INJECTIONS FOR CORRECTING CALCIUM DEFICIENCYEXPIREDDec 7, 1944

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 13, 2006CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Nov 4, 2004ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 4, 2004REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 7, 1986REN2REGISTERED AND RENEWED (SECOND RENEWAL - 20 YRS)—
Apr 9, 1986PRA9POST REGISTRATION ACTION MAILED - SEC. 9—
Sep 19, 1985PRA9POST REGISTRATION ACTION MAILED - SEC. 9—
May 23, 19859.AFREGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8—

Frequently asked questions

Related guidance